Our Company
Shenzhen Anieasy Biotechnology Co., Ltd, founded in 2022, is a wholly-owned subsidiary of Shenzhen Bioeasy Biotechnology Co., Ltd, (stock code 300942), which is a company listed on China A-share GEM board.
Anieasy cares about animal health and dedicates ourselves on the diagnostic kits for ruminant, swine, avian and companion animal , with the mission of "Innovate with animal health and well-being", providing the whole industry with the world's leading veterinary diagnostic kits and animal health products, one stop services and total solutions.

Anieasy has immunological diagnostic products (Class B) production lines and molecular biology diagnostic products (Class B) production lines, and has passed the GMP inspection of veterinary diagnostic products. The company has strong research, advanced capability and multiple cutting-edge research and development technology platforms, including the research and development platform of antigen and antibody diagnostic raw materials, immunodiagnostic technology platform (colloidal gold immunochromatography, fluorescent immunochromatography, ELISA, etc.), molecular diagnostic technology platform (fluorescent PCR, etc.) and animal innovative high-efficiency vaccine technology platform for new mRNA Development of animal vaccines, has applied for a number of mRNA technology-related patents. Anieasy has a perfect quality control management system, has passed three major system certifications of ISO9001 quality management system, ISO14001 environmental management system, and ISO45001 occupational health and safety management system, continues to provide customers with world-class quality products.
At present, we have obtained
6 patents
(covering the detection methods of African swine fever virus and bovine mastitis pathogenic bacteria, etc)
Participated in drafting
3 local standards
3 new veterinary drug certificate
3 technology transfer products
Cooperated to develop
11 products
" />
In addition, our holding company Bioeasy has established a joint laboratory for the development of animal diagnostic reagents and veterinary drugs with Veterinary Institute, Chinese Academy of Agricultural and Veterinary Medicine, Chinese Academy of Agricultural Sciences.

In the future, Anieasy will continue to launch cutting-edge veterinary diagnostic kits, animal health products, one stop services and total solutions for the industry domestically and globally, and strive to become a practitioner and innovator in the animal health field driven by technological innovation and with the mission of caring for animal health.
Our History
As a national high-tech enterprise, Bioeasy is committed to food safety, integrating research and development, production, sales, service and information construction in one. While deeply engaged in food safety, Bioeasy also focuses on veterinary diagnostic kits, especially in the field of cattle and sheep disease detection with strong technical advantages and research and development strength, and Anieasy was born out of this reason in January 2022.
Our holding company
New Veterinary Drug Certificate.
Covers an area of about 1250 m².
Our Vision
Our Mission
Innovate with animal health and well-being
Our Vision
To provide users with the world's leading rapid testing products, services and total solutions. Driven by technological innovation and with the mission of caring for animal health to benefit the entire animal health industry.
Our Values
Customer, result, innovation, quality, service, integrity, struggle, learning, cooperation
Our Partner
Our Representative Clients
Our Global Presence
More than
commercial users
More than
government users
More than
overseas distributors in total